ZW-1528

N/A

Report date: 2024/12/26 11:35:30

Base Information

Drug NameZW-1528
Drug Alias NameZW1528ZW-1528
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Interleukin-4 receptor subunit alphaAnti-Interleukin-33
TargetsInterleukin-4 receptor subunit alphaInterleukin-33
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZymeworks Inc
China Registration ClassN/A

Develop Information

Active CompaniesZymeworks Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A